dup 532 has been researched along with exp3174 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashton, WT; Chang, RS; Chen, TB; Doss, GA; Faust, KA; Greenlee, WJ; Hutchins, SM; Kivlighn, SD; Lotti, VJ; Zingaro, GJ | 1 |
Bunker, AM; Connolly, C; Edmunds, JJ; Hamby, JM; Hodges, JC; Kesten, SJ; Kostlan, CR; Quin, J; Sircar, I; Winters, RT | 1 |
Altenbach, RJ; Basha, FZ; Boyd, SA; Brune, ME; Buckner, SA; Crowell, D; De, B; Drizin, I; Winn, M; Zydowsky, TM | 1 |
Goldberg, MR; Greenlee, WJ; Irvin, JD; Prendergast, K; Smith, RD; Timmermans, PB; Wexler, RR | 1 |
Giridhar, R; Murumkar, P; Naik, P; Yadav, MR | 1 |
Bauer, JH; Reams, GP | 1 |
3 review(s) available for dup 532 and exp3174
Article | Year |
---|---|
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Receptors, Angiotensin; Structure-Activity Relationship | 1996 |
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan | 2010 |
The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs.
Topics: Acrylates; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Imidazoles; Irbesartan; Losartan; Pyridines; Quinolines; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 1995 |
3 other study(ies) available for dup 532 and exp3174
Article | Year |
---|---|
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Blood Pressure; Carboxylic Acids; Chemical Phenomena; Chemistry, Physical; Imidazoles; Male; Molecular Structure; Pyrazoles; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 1993 |
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoro
Topics: Angiotensin Receptor Antagonists; Animals; Aorta; Disease Models, Animal; GABA Antagonists; gamma-Aminobutyric Acid; Hypertension, Renal; Liver; Male; Muscle Contraction; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship | 1993 |
2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biological Availability; Iodine Radioisotopes; Liver; Male; Muscle Contraction; Niacin; Nicotinic Acids; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles | 1993 |